Artificial intelligence and chimeric antigen receptor T-cell therapy

Therapy with the use of chimeric antigen receptor T-cell (CAR T-cells) is one most modern medical technologies in hemato-oncology, using, thanks to advances molecular biology, natural anti-cancer immune mechanisms. Nowadays, it an extremely effective complement conventional treatment and hematopoietic cell transplantation. Ongoing clinical trials show enormous potential this beyond hemato-oncology. We discuss paper Artificial intelligence (AI) setting. AI has been at cutting edge science recent years. It spread from computer areas like medicine, economics, finance business. The research into medicine have become prominent due its versatility capabilities.